What is Adaptive Biotechnologies's capex?

Adaptive Biotechnologies (ADPT) reported capex of $796K in Q1 2026.

How has Adaptive Biotechnologies's capex changed year-over-year?

Adaptive Biotechnologies's capex decreased by 36.8% year-over-year, from $1.26M to $796K.

What is the long-term trend for Adaptive Biotechnologies's capex?

Over 4 years (2021 to 2025), Adaptive Biotechnologies's capex has grown at a -53.2% compound annual growth rate (CAGR), from $61.75M to $2.96M.

What does capex mean?

Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

Adaptive Biotechnologies ADPT CapEx

CapEx at other companies

Guardant HealthGH

$5.58M+25.1%

Natera, Inc.NTRA

$22.14M+1.5%

RevvityRVTY

$19.78M+23.7%

VeracyteVCYT

$2.96M+62.8%

DanaherDHR

$237M-3.3%

Charles River LaboratoriesCRL

$55.91M-5.8%

Other financials

Income statement

See full

Revenue$70.9M+35.1%

Gross profit$52.2M+47.1%

Operating income-$19.2M+35.1%

Net income-$20.0M+32.9%

EPS (diluted)-$0.13+35.0%

Balance sheet

See full

Cash & equivalents$77.6M+53.2%

Total debt$208.2M-5.6%

Total equity$216.3M+13.6%

Total assets$505.9M-1.0%

Cash flow

See full

Operating cash flow-$9.5M+66.5%

Free cash flow-$10.3M+65.3%

Valuation

See full

Market cap$2.76B+93.6%

Enterprise value$2.89B+78.0%

P/S9.3×+1.8×

Profitability

See full

Gross margin75.3%+12.7pp

Operating margin-15.8%-7.0pp

Net margin-16.8%-7.3pp

FCF margin-10.5%-4.6pp

Returns & leverage

See full

Return on equity-24.4%-9.2pp

Debt / equity1×-0.2×

Current ratio3.4×+0.4×

Where this comes from

Reported directly by Adaptive Biotechnologies in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Adaptive Biotechnologies's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Adaptive Biotechnologies's capex?: Adaptive Biotechnologies (ADPT) reported capex of $796K in Q1 2026.
How has Adaptive Biotechnologies's capex changed year-over-year?: Adaptive Biotechnologies's capex decreased by 36.8% year-over-year, from $1.26M to $796K.
What is the long-term trend for Adaptive Biotechnologies's capex?: Over 4 years (2021 to 2025), Adaptive Biotechnologies's capex has grown at a -53.2% compound annual growth rate (CAGR), from $61.75M to $2.96M.
What does capex mean?: Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.